Combination therapy in the treatment of pulmonary arterial hypertension - 2015 update.
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2015, Vol 2, Issue 4
Abstract
Pulmonary arterial hypertension (PAH) is a disease with a poor prognosis and high mortality rates therefore in the era of advanced therapies targeting different patophysiological pathways attractive seems the idea of combining drugs from two or more classes. They can be applied sequentially or initially (upfront). Data from randomized clinical placebo controlled trials and observational studies show that both strategies can be successful in terms of improvement of functional capacity or delaying time to clinical worsening. The European Society of Cardiology guidelines on pulmonary hypertension issued in 2015 present in detail the role of combination therapy in the management of PAH.
Authors and Affiliations
Grzegorz Kopec, Piotr Podolec
Keywords
Related Articles
- EP ID EP242018
- DOI 10.20418/jrcd.vol2no4.204
- Views 112
- Downloads 0
Clinically silent, right and left ventricular outflow tract obstructions in an adult patient (RCD code: IV‑3A)
Right ventricular outflow tract obstruction is a narrowing of the way that conducts blood from the right ventricle to the pulmonary ar‑ tery. Left ventricular outflow tract obstruction is a stenosis of the path that lead...
Spirituality/religiosity of man from the perspective of quality of life – a review of Polish research in social studies
Research into the spirituality/religiosity of patients is considered as an important area of study, together with studies of quality of life (QoL).The purpose of this article was to recognise if and how the category of s...
Case report on aortic valve replacement in adult woman with systemic mastocytosis (RCD code: VIII)
We present a case of a 50 year-old woman who was referred to our department with severe symptomatic aortic stenosis and systemic mastocytosis. Conventional mechanical aortic valve replacement was performed successfully w...
Update on myocarditis – review (RCD code: III-6A.1)
Myocardits is an inflammatory disease of the myocardium diagnosed by established histological and immunohistochemical criteria. The true incidence of myocarditis is unknown. There are numerous potential etiologic factors...
Report from the 12th Meeting of the Myocardial and Pericardial Diseases Working Group of the European Society of Cardiology, 2015 in Florence, Italy
Nowadays, with a constant accumulation of data and knowledge, specialized and dedicated to particular problems meetings are thriving. The Working Group (WG) of the Myocardial and Peri‑ cardial Diseases of the European So...